Navigation Links
Fibrinogen may Inhibit Spinal Cord Regeneration

Fibrinogen, a blood-clotting protein found in circulating blood, has been found to inhibit the growth of central nervous system neuronal cells , a process that is necessary for the regeneration of the spinal cord after traumatic injury.

The findings by researchers at the University of California, San Diego (UCSD) School of Medicine, may explain why the human body is unable to repair itself after most spinal cord injuries.

The study, led by Katerina Akassoglou, Ph.D., assistant professor in UCSDs Department of Pharmacology, is the first evidence that when blood leaks into the nervous system, the blood protein contributes to the neurons inability to repair themselves.

The findings, which show the molecular link between vascular and neuronal damage during injury to the central nervous system, was published in the online issue of the Proceedings of the National Academy of Sciences on July 2.

The research team studied three types of spinal cord injuries in mice and rats which resulted in cellular and vascular damage, and leakage of fibrinogen from the blood vessels.

Once injured, neurons cannot be repaired because of various inhibitors that are present in the brain and the spinal cord after damage, which results in a patients paralysis. The researchers were surprised at the massive deposits of fibrinogen found at the sites of injury. That discovery led them to investigate the proteins effect on neuronal cells ability to regenerate.

Our study shows that fibrinogen directly affects neurons by inhibiting their ability for repair, said Akassoglou. Fibrinogen contained in the blood which leaks at the site of injury begins the process of inhibiting axonal growth by binding to the beta 3 integrin receptor.

This binding, in turn, induces the activation of another receptor on the neuronal cells, called the epidermal growth factor receptor. When the second receptor is activated, it inhibits the axonal growth. Other inhibitors have been identified that use the same epidermal growth factor receptor, but this is the first blood-derived inhibitor that has been found.

The discovery may open the door to a possible strategy to improving recovery after spinal cord injury by discovering a way to block activation of neuronal receptors by fibrinogen.

Identifying the specific inhibitors that impede the repair process could provide ways to regenerate and connect the damaged nerves and initiate recovery from paralysis after spinal cord injury.

Inhibiting the damaging effects of fibrinogen on neurons may potentially facilitate repair in the nervous system after injury said Akassoglou.

A similar mechanism could be at work in other neurological diseases that result in paralysis, such as multiple sclerosis or hemorrhagic stroke, where blood vessels break and bleed into the brain. She added that such a therapeutic approach wouldnt interfere with fibrinogens essential role in coagulation, because its blood-clotting mechanism depends on binding with a different receptor.


'"/>




Related medicine news :

1. Tomatoes Might Inhibit the Development Of Prostate Cancer
2. Identified Protein To Inhibit Cell Migration
3. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
4. Omega 3 Fatty acids (fishy oil) Inhibits Breast Cancer Growth
5. Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression
6. Inhibition of morphine tolerance by spinal melanocortin receptor blockade
7. Sugars Could Contain Key Cancer Inhibiting Compounds
8. Rejuvenation of Stem cells by GSK-3 Inhibitor
9. Anonymity Helps In Overcoming Inhibitions During Online Counseling
10. LipB Protein Inhibitors Help To Fight Against TB
11. Birth Defects Link With ACE Inhibitor Use, FDA Reports
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... ... 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The office opened earlier this ... physician assistants Lori Friedman and Fruma Leah Wiederman. , Advanced Dermatology, P.C. ...
(Date:7/24/2017)... ... , ... The Center for Addiction Recovery Training (CART), the ... second Multiple Pathways of Recovery Conference on October 23-26, 2017. This year, the ... foundational principle – a belief in multiple pathways of recovery, aims to bring ...
(Date:7/23/2017)... ... July 23, 2017 , ... Better education ... say researchers presenting their work today at the American Orthopaedic Society for ... is the first one to prospectively document the association between sports specialization and ...
(Date:7/23/2017)... ... 2017 , ... “Squiggy’s Outdoor Adventure”: a turtle’s backyard adventure that teaches the ... author, Paula Christian, a wife and mother to three amazing, and supportive, children. ... lives on God. She loves to tell stories to her children, play board ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung ... pleural catheters available on the market," said an inventor from Center Valley, Pa. "My ... for the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... 30, 2017 In vitro diagnostics market firm ... May, at least ten diagnostic companies have successfully completed ... offerings and a loan facility.  The size of these ... million.  Kalorama Information provides a monthly IVD Market ... Knowledge Center. ...
(Date:6/30/2017)... POINT, N.C. , June 29, 2017  Axium Pharmaceuticals Inc. ... for developing improved novel formulations and alternative dosage forms of ... ... delivery is based on our waterless self-nano emulsifying formula, which ... contact with saliva. We believe the spray will provide fast ...
Breaking Medicine Technology: